Literature DB >> 6356778

Cystic fibrosis mimicking Bartter's syndrome.

A G Davison, G J Snodgrass.   

Abstract

A four-month-old female presented with dehydration and an unexplained hypoelectrolytaemia and metabolic alkalosis in association with hyperreninaemia and hyperaldosteronism. These findings suggested Bartter's syndrome. Sweat sodium concentrations were within normal limits. Total skin water loss was estimated and found to be sufficient for the sodium loss in the sweat to exceed the dietary intake. Reinvestigation at three years revealed normal plasma electrolytes, plasma renin activity and aldosterone values but sweat sodium concentrations were in excess of 80 mmol/l, indicating a diagnosis of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356778     DOI: 10.1111/j.1651-2227.1983.tb09814.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Elevated sweat potassium, hyperaldosteronism and pseudo-Bartter's syndrome: a spectrum of disorders associated with cystic fibrosis.

Authors:  J Devlin; N S Beckett; T J David
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 2.  Anesthetic management of a patient with Bartter's syndrome undergoing orthognathic surgery.

Authors:  J A Roelofse; A J van der Westhuijzen
Journal:  Anesth Prog       Date:  1997

Review 3.  Electrolyte abnormalities in cystic fibrosis: systematic review of the literature.

Authors:  Elisabetta Scurati-Manzoni; Emilio F Fossali; Carlo Agostoni; Enrica Riva; Giacomo D Simonetti; Maura Zanolari-Calderari; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

4.  Sodium chloride deficiency in cystic fibrosis patients.

Authors:  U Ozçelik; A Göçmen; N Kiper; T Coşkun; E Yilmaz; M Ozgüç
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

5.  Chloride deficiency as a presentation or complication of cystic fibrosis.

Authors:  A Sojo; J Rodriguez-Soriano; J C Vitoria; C Vazquez; G Ariceta; A Villate
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.